|
Lymphoid Neoplasia
Citations 171-180 of 299 total displayed.
|
Past content
(since Jan 2009):
|
Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer
- Juan M. Zapata, David Llobet, Maryla Krajewska, Sophie Lefebvre, Christina L. Kress, and John C. Reed
Blood 2009; 113: 4595-4603.
[Abstract]
[Full text]
[PDF]
Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting
- Antonina V. Kurtova, Archito T. Tamayo, Richard J. Ford, and Jan A. Burger
Blood 2009; 113: 4604-4613.
[Abstract]
[Full text]
[PDF]
The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor
- Anne Catherine Sprynski, Dirk Hose, Laurent Caillot, Thierry Réme, John D. Shaughnessy, Jr, Bart Barlogie, Anja Seckinger, Jérôme Moreaux, Michael Hundemer, Michel Jourdan, Tobias Meißner, Anna Jauch, Karène Mahtouk, Alboukadel Kassambara, Uta Bertsch, Jean François Rossi, Hartmut Goldschmidt, and Bernard Klein
Blood 2009; 113: 4614-4626.
[Abstract]
[Full text]
[PDF]
BAFF-R promotes cell proliferation and survival through interaction with IKKβ and NF- B/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells
- Lingchen Fu, Yen-Chiu Lin-Lee, Lan V. Pham, Archito T. Tamayo, Linda C. Yoshimura, and Richard J. Ford
Blood 2009; 113: 4627-4636.
[Abstract]
[Full text]
[PDF]
Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia
- Rong Chen, William G. Wierda, Sherri Chubb, Rachael E. Hawtin, Judith A. Fox, Michael J. Keating, Varsha Gandhi, and William Plunkett
Blood 2009; 113: 4637-4645.
[Abstract]
[Full text]
[PDF]
Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells
- Erin Kennah, Ashley Ringrose, Liang L. Zhou, Sharmin Esmailzadeh, Hong Qian, Ming-wan Su, Youwen Zhou, and Xiaoyan Jiang
Blood 2009; 113: 4646-4655.
[Abstract]
[Full text]
[PDF]
The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo
- David M. Lucas, Ryan B. Edwards, Gerard Lozanski, Derek A. West, Jungook D. Shin, Melissa A. Vargo, Melanie E. Davis, Darlene M. Rozewski, Amy J. Johnson, Bao-Ning Su, Virginia M. Goettl, Nyla A. Heerema, Thomas S. Lin, Amy Lehman, Xiaoli Zhang, David Jarjoura, David J. Newman, John C. Byrd, A. Douglas Kinghorn, and Michael R. Grever
Blood 2009; 113: 4656-4666.
[Abstract]
[Full text]
[PDF]
Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors
- Deborah J. Kuhn, Sally A. Hunsucker, Qing Chen, Peter M. Voorhees, Marian Orlowski, and Robert Z. Orlowski
Blood 2009; 113: 4667-4676.
[Abstract]
[Full text]
[PDF]
Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development
- Katy J. McCann, Margaret Ashton-Key, KellyAnn Smith, Freda K. Stevenson, and Christian H. Ottensmeier
Blood 2009; 113: 4677-4680.
[Abstract]
[Full text]
[PDF]
Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)
- Stefan Knop, Christian Gerecke, Peter Liebisch, Max S. Topp, Uwe Platzbecker, Orhan Sezer, Christina Vollmuth, Karina Falk, Axel Glasmacher, Uwe Maeder, Hermann Einsele, and Ralf C. Bargou
Blood 2009; 113: 4137-4143.
[Abstract]
[Full text]
[PDF]
|
|
